{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:41:19Z","timestamp":1787164879722,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82060169"],"award-info":[{"award-number":["82060169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81960392"],"award-info":[{"award-number":["81960392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Currently, the etiology of idiopathic short stature (ISS) is still unclear. The poor understanding of the molecular mechanisms of ISS has largely restricted this strategy towards safe and effective clinical therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The plasma exosomes of ISS children were co-cultured with normal human chondrocytes. The differential expression of exosome miRNA between ISS and normal children was identified via high-throughput microRNA sequencing and bioinformatics analysis. Immunohistochemistry, In situ hybridization, RT-qPCR, western blotting, luciferase expression, and gene overexpression and knockdown were performed to reveal the key signaling pathways that exosome miRNA of aberrant expression in ISS children impairs longitudinal bone growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Chondrocytes proliferation and endochondral ossification were suppressed after coculture of ISS plasma exosomes with human normal chondrocytes. High-throughput microRNA sequencing and RT-qPCR confirmed that plasma exosome miR-26b-3p was upregulated in ISS children. Meanwhile, exosome miRNA-26b-3p showed a high specificity and sensitivity in discriminating ISS from normal children. The rescue experiment showed that downregulation of miR-26b-3p obviously improved the repression of chondrocyte proliferation and endochondral ossification caused by ISS exosomes. Subsequently, miR-26b-3p overexpression inhibited chondrocyte proliferation and endochondral ossification once again. In situ hybridization confirmed the colocalization of miR-26b-3p with AKAP2 in chondrocytes. In vitro and in vivo assay revealed exosome miRNA-26b-3p impairs longitudinal bone growth via the AKAP2 \/ERK1\/2 axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study is the first to confirm that miR-26b-3p overexpression in ISS plasma exosomes leads to disorders in proliferation and endochondral ossification of growth plate cartilage via inhibition of AKAP2\/ERK1\/2 axis, thereby inducing ISS. This study provides a new research direction for the etiology and pathology of ISS and a new idea for the biological treatment of ISS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-023-01849-8","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:15:12Z","timestamp":1678986912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Plasma exosome miRNA-26b-3p derived from idiopathic short stature impairs longitudinal bone growth via the AKAP2\/ERK1\/2 axis"],"prefix":"10.1186","volume":"21","author":[{"given":"Xijuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"1849_CR1","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1210\/jc.2008-0509","volume":"93","author":"P Cohen","year":"2008","unstructured":"Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM. Participants ISSCW: Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93:4210\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1849_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF03344012","volume":"25","author":"E Molinari","year":"2002","unstructured":"Molinari E, Sartori A, Ceccarelli A, Marchi S. Psychological and emotional development, intellectual capabilities, and body image in short normal children. J Endocrinol Invest. 2002;25:321\u20138.","journal-title":"J Endocrinol Invest"},{"key":"1849_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ghir.2007.11.004","volume":"18","author":"JM Wit","year":"2008","unstructured":"Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res. 2008;18:89\u2013110.","journal-title":"Growth Horm IGF Res"},{"key":"1849_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ghir.2005.08.004","volume":"15","author":"E Bonioli","year":"2005","unstructured":"Bonioli E, Taro M, Rosa CL, Citana A, Bertorelli R, Morcaldi G, Gastaldi R, Coviello DA. Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature. Growth Horm IGF Res. 2005;15:405\u201310.","journal-title":"Growth Horm IGF Res"},{"key":"1849_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000338341","volume":"77","author":"J Caliebe","year":"2012","unstructured":"Caliebe J, Broekman S, Boogaard M, Bosch CA, Ruivenkamp CA, Oostdijk W, Kant SG, Binder G, Ranke MB, Wit JM, Losekoot M. IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature). Horm Res Paediatr. 2012;77:250\u201360.","journal-title":"Horm Res Paediatr"},{"key":"1849_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1297\/cpe.15.61","volume":"15","author":"M Mamada","year":"2006","unstructured":"Mamada M, Yorifuji T, Kurokawa K, Kawai M, Momoi T, Nakahata T. Prevalence of mutations in the FGFR3 gene in individuals with idiopathic short stature. Clin Pediatr Endocrinol. 2006;15:61\u20134.","journal-title":"Clin Pediatr Endocrinol"},{"key":"1849_CR7","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.1038\/s41598-017-12465-6","volume":"7","author":"NN Hauer","year":"2017","unstructured":"Hauer NN, Sticht H, Boppudi S, Buttner C, Kraus C, Trautmann U, Zenker M, Zweier C, Wiesener A, Jamra RA, et al. Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature. Sci Rep. 2017;7:12225.","journal-title":"Sci Rep"},{"key":"1849_CR8","doi-asserted-by":"publisher","first-page":"E1636","DOI":"10.1210\/jc.2013-2142","volume":"98","author":"GA Vasques","year":"2013","unstructured":"Vasques GA, Amano N, Docko AJ, Funari MF, Quedas EP, Nishi MY, Arnhold IJ, Hasegawa T, Jorge AA. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. J Clin Endocrinol Metab. 2013;98:E1636-1644.","journal-title":"J Clin Endocrinol Metab"},{"key":"1849_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/pmic.201200131","volume":"13","author":"SH Heo","year":"2013","unstructured":"Heo SH, Choi JH, Kim YM, Jung CW, Lee J, Jin HY, Kim GH, Lee BH, Shin CH, Yoo HW. Comparative proteomic analysis in children with idiopathic short stature (ISS) before and after short-term recombinant human growth hormone (rhGH) therapy. Proteomics. 2013;13:1211\u20139.","journal-title":"Proteomics"},{"key":"1849_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ghir.2018.09.003","volume":"42\u201343","author":"YQ Ying","year":"2018","unstructured":"Ying YQ, Hou L, Liang Y, Wu W, Luo XP. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature. Growth Horm IGF Res. 2018;42\u201343:80\u20135.","journal-title":"Growth Horm IGF Res"},{"key":"1849_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000502901","volume":"92","author":"E Inzaghi","year":"2019","unstructured":"Inzaghi E, Reiter E, Cianfarani S. The challenge of defining and investigating the causes of idiopathic short stature and finding an effective therapy. Horm Res Paediatr. 2019;92:71\u201383.","journal-title":"Horm Res Paediatr"},{"key":"1849_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/EJE-09-0880","volume":"162","author":"SA Van Gool","year":"2010","unstructured":"Van Gool SA, Kamp GA, Odink RJ, de Muinck Keizer-Schrama SM, Delemarre-van de Waal HA, Oostdijk W, Wit JM. High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height. Eur J Endocrinol. 2010;162:653\u201360.","journal-title":"Eur J Endocrinol."},{"key":"1849_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1210\/jc.2011-1995","volume":"97","author":"JC Carel","year":"2012","unstructured":"Carel JC, Ecosse E, Landier F, Meguellati-Hakkas D, Kaguelidou F, Rey G, Coste J. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab. 2012;97:416\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"1849_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1212\/WNL.0000000000000737","volume":"83","author":"A Poidvin","year":"2014","unstructured":"Poidvin A, Touze E, Ecosse E, Landier F, Bejot Y, Giroud M, Rothwell PM, Carel JC, Coste J. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurology. 2014;83:780\u20136.","journal-title":"Neurology"},{"key":"1849_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/cen.13502","volume":"88","author":"K Stochholm","year":"2018","unstructured":"Stochholm K, Kiess W. Long-term safety of growth hormone-a combined registry analysis. Clin Endocrinol (Oxf). 2018;88:515\u201328.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1849_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH, Drug, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86:361\u201397.","journal-title":"Horm Res Paediatr."},{"key":"1849_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1542\/peds.2009-3609","volume":"126","author":"JB Silvers","year":"2010","unstructured":"Silvers JB, Marinova D, Mercer MB, Connors A, Cuttler L. A national study of physician recommendations to initiate and discontinue growth hormone for short stature. Pediatrics. 2010;126:468\u201376.","journal-title":"Pediatrics"},{"key":"1849_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R, Grinspoon SK, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542:450\u20135.","journal-title":"Nature"},{"key":"1849_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.immuni.2019.02.019","volume":"50","author":"VS LeBleu","year":"2019","unstructured":"LeBleu VS, Kalluri R. Exosomes exercise inhibition of anti-tumor immunity during chemotherapy. Immunity. 2019;50:547\u20139.","journal-title":"Immunity"},{"key":"1849_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature23282","volume":"548","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kim MS, Jia B, Yan J, Zuniga-Hertz JP, Han C, Cai D. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature. 2017;548:52\u20137.","journal-title":"Nature"},{"key":"1849_CR21","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J, Zhou K, Liu X, Ren X, Wang F, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9:5395.","journal-title":"Nat Commun"},{"key":"1849_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000376","volume":"8","author":"XX Peng","year":"2020","unstructured":"Peng XX, Yu R, Wu X, Wu SY, Pi C, Chen ZH, Zhang XC, Gao CY, Shao YW, Liu L, et al. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR\/ALK wild-type advanced non-small cell lung cancer. J Immunother Cancer. 2020;8: e000376.","journal-title":"J Immunother Cancer."},{"key":"1849_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1039\/C9NR09011H","volume":"12","author":"H Nie","year":"2020","unstructured":"Nie H, Xie X, Zhang D, Zhou Y, Li B, Li F, Li F, Cheng Y, Mei H, Meng H, Jia L. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. Nanoscale. 2020;12:877\u201387.","journal-title":"Nanoscale"},{"key":"1849_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41467-019-08895-7","volume":"10","author":"M Cheng","year":"2019","unstructured":"Cheng M, Yang J, Zhao X, Zhang E, Zeng Q, Yu Y, Yang L, Wu B, Yi G, Mao X, et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat Commun. 2019;10:959.","journal-title":"Nat Commun"},{"key":"1849_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41467-017-02406-2","volume":"9","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hohjoh H, Fukuoka M, Sato W, Oki S, Tomi C, Yamaguchi H, Kondo T, Takahashi R, Yamamura T. Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat Commun. 2018;9:17.","journal-title":"Nat Commun"},{"key":"1849_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12631","volume":"68","author":"F Xu","year":"2020","unstructured":"Xu F, Zhong JY, Lin X, Shan SK, Guo B, Zheng MH, Wang Y, Li F, Cui RR, Wu F, et al. Melatonin alleviates vascular calcification and ageing through exosomal miR-204\/miR-211 cluster in a paracrine manner. J Pineal Res. 2020;68: e12631.","journal-title":"J Pineal Res"},{"key":"1849_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121242","volume":"279","author":"W Feng","year":"2021","unstructured":"Feng W, Jin Q, Ming-Yu Y, Yang H, Xu T, You-Xing S, Xu-Ting B, Wan C, Yun-Jiao W, Huan W, et al. MiR-6924-5p-rich exosomes derived from genetically modified Scleraxis-overexpressing PDGFRalpha(+) BMMSCs as novel nanotherapeutics for treating osteolysis during tendon-bone healing and improving healing strength. Biomaterials. 2021;279: 121242.","journal-title":"Biomaterials"},{"key":"1849_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan JK, He JY, Li S, Liu YS. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther. 2021;6:383.","journal-title":"Signal Transduct Target Ther"},{"key":"1849_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101497","volume":"73","author":"L Su","year":"2022","unstructured":"Su L, Li R, Zhang Z, Liu J, Du J, Wei H. Identification of altered exosomal microRNAs and mRNAs in Alzheimer\u2019s disease. Ageing Res Rev. 2022;73: 101497.","journal-title":"Ageing Res Rev"},{"key":"1849_CR30","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/07420528.2020.1797765","volume":"37","author":"R Stawerska","year":"2020","unstructured":"Stawerska R, Kolasa-Kicinska M, Lupinska A, Hilczer M, Lewinski A. Comparison of nocturnal and morning ghrelin concentration in children with growth hormone deficiency and with idiopathic short stature. Chronobiol Int. 2020;37:1629\u201335.","journal-title":"Chronobiol Int"},{"key":"1849_CR31","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1111\/jcmm.16419","volume":"25","author":"X Liu","year":"2021","unstructured":"Liu X, Du Z, Yi X, Sheng T, Yuan J, Jia J. Circular RNA circANAPC2 mediates the impairment of endochondral ossification by miR-874-3p\/SMAD3 signalling pathway in idiopathic short stature. J Cell Mol Med. 2021;25:3408\u201326.","journal-title":"J Cell Mol Med"},{"key":"1849_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ygeno.2018.07.003","volume":"111","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xiao L, Zhang Y, Li P, Wu Y, Lin Y. MiR-26b-3p regulates osteoblast differentiation via targeting estrogen receptor alpha. Genomics. 2019;111:1089\u201396.","journal-title":"Genomics"},{"key":"1849_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115875","volume":"146","author":"B Wang","year":"2021","unstructured":"Wang B, Jiang B, Li Y, Dai Y, Li P, Li L, Xu J, Li L, Wu P. AKAP2 overexpression modulates growth plate chondrocyte functions through ERK1\/2 signaling. Bone. 2021;146: 115875.","journal-title":"Bone"},{"key":"1849_CR34","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.ejca.2012.11.020","volume":"49","author":"LM McGlynn","year":"2013","unstructured":"McGlynn LM, Tovey S, Bartlett JM, Doughty J, Cooke TG, Edwards J. Interactions between MAP kinase and oestrogen receptor in human breast cancer. Eur J Cancer. 2013;49:1176\u201386.","journal-title":"Eur J Cancer"},{"key":"1849_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105946","volume":"78","author":"Z Jin","year":"2020","unstructured":"Jin Z, Ren J, Qi S. Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2. Int Immunopharmacol. 2020;78: 105946.","journal-title":"Int Immunopharmacol"},{"key":"1849_CR36","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1039\/C7NR00352H","volume":"9","author":"X Liu","year":"2017","unstructured":"Liu X, Yang Y, Li Y, Niu X, Zhao B, Wang Y, Bao C, Xie Z, Lin Q, Zhu L. Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. Nanoscale. 2017;9:4430\u20138.","journal-title":"Nanoscale"},{"key":"1849_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00109-020-01882-2","volume":"98","author":"D Liu","year":"2020","unstructured":"Liu D, Fang Y, Rao Y, Tan W, Zhou W, Wu X, Zhang C, Zhang Y, Liu Y, Sunagawa M, et al. Synovial fibroblast-derived exosomal microRNA-106b suppresses chondrocyte proliferation and migration in rheumatoid arthritis via down-regulation of PDK4. J Mol Med (Berl). 2020;98:409\u201323.","journal-title":"J Mol Med (Berl)"},{"key":"1849_CR38","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/jcb.29657","volume":"121","author":"G Won Lee","year":"2020","unstructured":"Won Lee G, Thangavelu M, Joung Choi M, Yeong Shin E, Sol Kim H, Seon Baek J, Woon Jeong Y, Eun Song J, Carlomagno C, Miguel Oliveira J, et al. Exosome mediated transfer of miRNA-140 promotes enhanced chondrogenic differentiation of bone marrow stem cells for enhanced cartilage repair and regeneration. J Cell Biochem. 2020;121:3642\u201352.","journal-title":"J Cell Biochem"},{"key":"1849_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/brv.12353","volume":"93","author":"S Zhu","year":"2018","unstructured":"Zhu S, Yao F, Qiu H, Zhang G, Xu H, Xu J. Coupling factors and exosomal packaging microRNAs involved in the regulation of bone remodelling. Biol Rev Camb Philos Soc. 2018;93:469\u201380.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"1849_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320.","journal-title":"Cell"},{"key":"1849_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/scd.2015.0267","volume":"25","author":"Q Wang","year":"2016","unstructured":"Wang Q, Xu C, Zhao Y, Xu Z, Zhang Y, Jiang J, Yan B, Gu D, Wu M, Wang Y, Liu H. miR-26b-3p regulates human umbilical cord-derived mesenchymal stem cell proliferation by targeting estrogen receptor. Stem Cells Dev. 2016;25:415\u201326.","journal-title":"Stem Cells Dev"},{"key":"1849_CR42","first-page":"7568","volume":"11","author":"F Geng","year":"2019","unstructured":"Geng F, Lu GF, Ji MH, Kong DY, Wang SY, Tian H, Xie ZM, Pan M, Gong NL. MicroRNA-26b-3p\/ANTXR1 signaling modulates proliferation, migration, and apoptosis of glioma. Am J Transl Res. 2019;11:7568\u201378.","journal-title":"Am J Transl Res"},{"key":"1849_CR43","first-page":"429","volume":"19","author":"E Panza","year":"2007","unstructured":"Panza E, Gimelli G, Passalacqua M, Cohen A, Gimelli S, Giglio S, Ghezzi C, Sparatore B, Heye B, Zuffardi O, et al. The breakpoint identified in a balanced de novo translocation t(7;9)(p14.1;q31.3) disrupts the A-kinase (PRKA) anchor protein 2 gene (AKAP2) on chromosome 9 in a patient with Kallmann syndrome and bone anomalies. Int J Mol Med. 2007;19:429\u201335.","journal-title":"Int J Mol Med."},{"key":"1849_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jmedgenet-2015-103684","volume":"53","author":"W Li","year":"2016","unstructured":"Li W, Li Y, Zhang L, Guo H, Tian D, Li Y, Peng Y, Zheng Y, Dai Y, Xia K, et al. AKAP2 identified as a novel gene mutated in a Chinese family with adolescent idiopathic scoliosis. J Med Genet. 2016;53:488\u201393.","journal-title":"J Med Genet"},{"key":"1849_CR45","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1002\/jbmr.156","volume":"25","author":"AE Borjesson","year":"2010","unstructured":"Borjesson AE, Lagerquist MK, Liu C, Shao R, Windahl SH, Karlsson C, Sjogren K, Moverare-Skrtic S, Antal MC, Krust A, et al. The role of estrogen receptor alpha in growth plate cartilage for longitudinal bone growth. J Bone Miner Res. 2010;25:2690\u2013700.","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01849-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T18:02:45Z","timestamp":1678989765000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01849-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01849-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"7 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this research was obtained from the Human and Animal Research Ethics Committee of the Second Affiliated Hospital of Nanchang University (Nanchang, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Informed written consent was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}